The AFCRPLITY score for predicting the prognosis of immunotherapy combined with local–regional therapy in unresectable hepatocellular carcinoma
Mengxuan Zuo, Ran Wei, Da Li, Wang Li, Chao An · 2024
Read The AFCRPLITY score for predicting the prognosis of immunotherapy combined with local–regional therapy in unresectable hepatocellular carcinoma by Mengxuan Zuo, Ran Wei, Da Li, Wang Li, Chao An (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574904.txt.
Description
Mengxuan Zuo and co-authors report a 2024 study that builds a score to forecast outcomes for liver cancer patients who cannot have surgery. These patients often get immune therapy joined with treatment delivered through the liver's artery. No marker could predict who would do well on that mix, so the team set out to build one.
They studied over a thousand patients treated between 2019 and 2022 at several centers. One group was used to build the score, and other groups tested it. The score rests on simple blood values, including a tumor marker and a swelling marker. An easy, tested score could help doctors plan care and counsel patients.
Catalog record
| CREATOR | Mengxuan Zuo, Ran Wei, Da Li, Wang Li, Chao An |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |